Respiratory Pathways
18 pathways
Work through 18 interactive respiratory decision pathways — branching, guideline-grounded workflows that take you from presentation to assessment, risk stratification and management. Each pathway cites its source (NICE, ESC, AHA and specialty guidance), embeds the relevant calculators, and makes escalation and safety-netting explicit. For decision support only — apply clinical judgement and local protocols.
- COPD Exacerbation ManagementAssessment and management of acute COPD exacerbation including controlled oxygen and NIV decisionNICE NG115 / GOLD 2024
- Community-Acquired Pneumonia (CURB-65)Risk stratification and antibiotic selection for community-acquired pneumonia using CURB-65BTS 2009 / NICE NG138
- Acute Pulmonary EmbolismDiagnosis and management of acute PE including risk stratification and anticoagulationBTS 2003 / ESC 2019
- Pleural Effusion AssessmentSystematic evaluation of pleural effusion — transudates vs exudates and managementBTS 2010
- Oxygen PrescribingSafe oxygen prescribing — target saturations and devices for different clinical scenariosBTS 2017
- Suspected Lung Cancer Pathway2-week wait pathway for suspected lung cancer — investigation and referralNICE NG12 / NICE NG122
- Acute Severe Asthma in AdultsBTS/SIGN/NICE NG80 — severity stratification, oxygen, salbutamol/ipratropium, IV magnesium, escalation criteria.BTS/SIGN 2019; NICE NG80
- Pleural Infection / EmpyemaBTS 2023 — recognition, pleural fluid analysis (pH, biochemistry), chest drain criteria, intrapleural fibrinolytics, surgical referral.BTS Pleural Disease 2023
- Hospital-Acquired PneumoniaNICE NG139 — early- vs late-onset, empirical antibiotics by severity + risk factors, escalation criteria.NICE NG139; ATS/IDSA 2016
- Active Tuberculosis — Diagnosis & ManagementNICE NG33 — clinical recognition, diagnostics (sputum, NAAT, culture), standard 6-month RIPE regimen, monitoring, public-health notification.NICE NG33 (2016, updates 2019); WHO 2022
- Bronchiectasis ExacerbationBTS 2019 — increased symptoms (cough, sputum volume/purulence, dyspnoea, malaise) — tailored antibiotics by colonisation, airway clearance, escalation triggers.BTS Bronchiectasis 2019
- Acute Respiratory Distress Syndrome (ARDS)Berlin definition, lung-protective ventilation (low TV, plateau pressure, prone positioning, PEEP), conservative fluids, treat cause.Berlin 2012; ESICM 2023; ATS/ESICM/SCCM
- Massive HaemoptysisDefinition: >200–600 mL/24h or any haemodynamic compromise — airway protection, lateralise, urgent CT angiography, bronchial artery embolisation.BTS / ERS
- Aspiration Pneumonia / PneumonitisDistinguish chemical pneumonitis from bacterial pneumonia, supportive care, antibiotic decision, prevent recurrence.ATS/IDSA 2019; BTS
- Cystic Fibrosis Acute ExacerbationCF Trust UK — IV antibiotics matched to colonisation, airway clearance, nutrition, PERT, CFTR modulator continuation.CF Trust UK Antibiotic Management 2009 (review); ECFS
- Obstructive Sleep Apnoea WorkupSTOP-BANG screening, sleep study (oximetry / polysomnography), CPAP, lifestyle, surgical referral when appropriate.BTS/SIGN; NICE NG202
- Acute Respiratory Failure / NIV IndicationsType 1 vs Type 2 respiratory failure, oxygen targets, NIV/CPAP indications and contraindications, escalation to invasive ventilation.BTS/ICS 2016; BTS Oxygen 2017
- Incidental Pulmonary Nodule (Fleischner)BTS / Fleischner 2017 — risk stratification by size, character, smoking history; surveillance vs biopsy vs PET-CT.BTS Pulmonary Nodules 2015; Fleischner 2017